Literature DB >> 9342729

Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage.

Y Hirashima1, S Nakamura, S Endo, N Kuwayama, Y Naruse, A Takaku.   

Abstract

The aim of the present study was to examine the changes of inflammatory and coagulation factors in blood of the internal jugular vein, not of peripheral vein, in patients with subarachnoid hemorrhage (SAH). The results show that while interleukin-6 (IL-6) and platelet activating factor (PAF) concentrations increased within first 4 days after SAH and remained elevated up to 14 days, interleukin-1 beta (IL-1 beta) showed a transient increase between 5-9 days after SAH and tumor necrosis factor-alpha (TNF-alpha) remained unchanged. Also different coagulation factors were increased between 5-9 days after SAH. Moreover, patients with delayed ischemic neurological deficits (DIND) displayed the highest levels of PAF and the coagulation factors, von Willebrand factor (vWF) and thrombin-antithrombin III complex (TAT). These results suggest that elevation of PAF and other inflammatory cytokines following SAH may cause the hypercoagulation state that is associated with cerebral vasospasm and internal jugular vein may be more adequate vessel for sampling blood to examine these factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9342729     DOI: 10.1023/a:1021985030331

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

1.  Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.

Authors:  H J Weiss; J Hawiger; Z M Ruggeri; V T Turitto; P Thiagarajan; T Hoffmann
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

3.  Letter: Aggregation of human platelets by platelet-activating factor.

Authors:  J Benveniste; J P Le Couedic; P Kamoun
Journal:  Lancet       Date:  1975-02-08       Impact factor: 79.321

4.  Cerebral vasospasm and ultrastructural changes in cerebral arterial wall. An experimental study.

Authors:  Y Tanabe; K Sakata; H Yamada; T Ito; M Takada
Journal:  J Neurosurg       Date:  1978-08       Impact factor: 5.115

5.  Regional disparity in the vascular response to subarachnoid hemorrhage--relationship between alteration of the concentration of eicosanoids and electron microscopic findings.

Authors:  S Nakamura; K Yoshida; T Tsubokawa
Journal:  Neurol Med Chir (Tokyo)       Date:  1989-03       Impact factor: 1.742

6.  Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage.

Authors:  T Mathiesen; B Andersson; A Loftenius; H von Holst
Journal:  J Neurosurg       Date:  1993-04       Impact factor: 5.115

7.  Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage.

Authors:  Y Hirashima; S Endo; M Kurimoto; E Tsukamoto; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

8.  Cytokine appearance in human endotoxemia and primate bacteremia.

Authors:  D G Hesse; K J Tracey; Y Fong; K R Manogue; M A Palladino; A Cerami; G T Shires; S F Lowry
Journal:  Surg Gynecol Obstet       Date:  1988-02

9.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; R S Cotran; M A Gimbrone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  44 in total

1.  Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and clazosentan.

Authors:  Jared M Pisapia; Xiangsheng Xu; Jane Kelly; Jamie Yeung; Geneive Carrion; Huaiyu Tong; Sudha Meghan; Omar M El-Falaky; M Sean Grady; Douglas H Smith; Sergei Zaitsev; Vladimir R Muzykantov; Michael F Stiefel; Sherman C Stein
Journal:  Exp Neurol       Date:  2011-11-04       Impact factor: 5.330

2.  RAR-Related Orphan Receptor Gamma T (RoRγt)-Related Cytokines Play a Role in Neutrophil Infiltration of the Central Nervous System After Subarachnoid Hemorrhage.

Authors:  A P Coulibaly; W T Gartman; V Swank; J A Gomes; L Ruozhuo; J DeBacker; J J Provencio
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

Review 3.  Neuroprotection in subarachnoid hemorrhage.

Authors:  Daniel T Laskowitz; Brad J Kolls
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

4.  Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome.

Authors:  C J M Frijns; R Fijnheer; A Algra; J A van Mourik; J van Gijn; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 5.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

Review 6.  Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome.

Authors:  Nyika D Kruyt; Geert Jan Biessels; J Hans DeVries; Merel J A Luitse; Marinus Vermeulen; Gabriel J E Rinkel; W Peter Vandertop; Yvo B Roos
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

7.  The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms.

Authors:  L Morgan; J Cooper; H Montgomery; N Kitchen; S E Humphries
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-28       Impact factor: 10.154

Review 8.  Brain ischemia in patients with intracranial hemorrhage: pathophysiological reasoning for aggressive diagnostic management.

Authors:  Daniel Naranjo; Michal Arkuszewski; Wojciech Rudzinski; Elias R Melhem; Jaroslaw Krejza
Journal:  Neuroradiol J       Date:  2013-12-18

Review 9.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

10.  TNF-alpha and sICAM-1 in intracranial aneurismal rupture.

Authors:  Anna Maria Witkowska; Maria Halina Borawska; Katarzyna Socha; Jan Kochanowicz; Zenon Mariak; Maria Konopka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-04-02       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.